Home › Kanser sa Bibig
Pag-aaral pangklinika para sa Kanser sa Bibig na nagre-recruit sa U.S.
45 pag-aaral para sa Kanser sa Bibig ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Atlanta, GA8 pag-aaral
- Chicago, IL8 pag-aaral
- St. Louis, MO8 pag-aaral
- New York City, NY8 pag-aaral
- Nashville, TN7 pag-aaral
- Richmond, VA7 pag-aaral
- Houston, TX7 pag-aaral
- Durham, NC7 pag-aaral
- Pittsburgh, PA7 pag-aaral
- Milwaukee, WI7 pag-aaral
- Portland, OR7 pag-aaral
- Ann Arbor, MI7 pag-aaral
- Kansas City, MO6 pag-aaral
- Edison, NJ6 pag-aaral
- Oklahoma City, OK6 pag-aaral
- Omaha, NE6 pag-aaral
- Mountain View, CA5 pag-aaral
- Baltimore, MD5 pag-aaral
- Kansas City, KS5 pag-aaral
- Erie, PA5 pag-aaral
- Detroit, MI5 pag-aaral
- Queens, NY5 pag-aaral
- Cedar Rapids, IA5 pag-aaral
- Aurora, IL5 pag-aaral
- Champaign, IL5 pag-aaral
- Charleston, IL5 pag-aaral
- Irvine, CA5 pag-aaral
- Naperville, IL5 pag-aaral
- Cicero, IL5 pag-aaral
- Joliet, IL5 pag-aaral
- Danville, IL5 pag-aaral
- Overland Park, KS4 pag-aaral
- Newark, NJ4 pag-aaral
- Cincinnati, OH4 pag-aaral
- Cleveland, OH4 pag-aaral
- Little Rock, AR4 pag-aaral
- Gresham, OR4 pag-aaral
- Charleston, SC4 pag-aaral
- San Diego, CA4 pag-aaral
- Youngstown, OH4 pag-aaral
Ayos sa estado
- Arizona6 pag-aaral
- Arkansas5 pag-aaral
- California12 pag-aaral
- Colorado9 pag-aaral
- Connecticut3 pag-aaral
- Florida9 pag-aaral
- Georgia8 pag-aaral
- Idaho3 pag-aaral
- Illinois10 pag-aaral
- Indiana4 pag-aaral
- Iowa8 pag-aaral
- Kansas8 pag-aaral
- Kentucky5 pag-aaral
- Louisiana3 pag-aaral
- Maryland6 pag-aaral
- Massachusetts5 pag-aaral
- Michigan9 pag-aaral
- Minnesota8 pag-aaral
- Missouri10 pag-aaral
- Montana4 pag-aaral
- Nebraska6 pag-aaral
- New Hampshire5 pag-aaral
- New Jersey8 pag-aaral
- New Mexico3 pag-aaral
- New York12 pag-aaral
- North Carolina9 pag-aaral
- North Dakota4 pag-aaral
- Ohio13 pag-aaral
- Oklahoma6 pag-aaral
- Oregon7 pag-aaral
- Pennsylvania9 pag-aaral
- South Carolina5 pag-aaral
- South Dakota4 pag-aaral
- Tennessee10 pag-aaral
- Texas9 pag-aaral
- Vermont4 pag-aaral
- Virginia7 pag-aaral
- Wisconsin9 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05172245BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05136196Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06589804Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07741565Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04265430Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06627270Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT04198766Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Nagre-recruitObservasyonal na pag-aaral
Edad 21 hanggang 90 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT00900419Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT07156227TMV Vaccine Alone or With Toripalimab-tpzi for Recurrent Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT07898124Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07195734Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT06980038Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT07460765Intraoperative Methadone for the Management of Postoperative Pain in Patients With Head and Neck Cancers
Nagre-recruitPhase 4
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07857655Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06997068DESTINY-PANTUMOUR04
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06736379Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 16, 2026 · NCT07343596Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT02734537Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06532279Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07110142Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06819228Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT07121595Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT06448026Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.